首页> 外文期刊>Analytical chemistry >Anti-Idiotype scFv-Enzyme Fusion Proteins: A Clonable Analyte-Mimicking Probe for Standardized Immunoassays Targeting Small Biomarkers
【24h】

Anti-Idiotype scFv-Enzyme Fusion Proteins: A Clonable Analyte-Mimicking Probe for Standardized Immunoassays Targeting Small Biomarkers

机译:抗独特型scFv酶融合蛋白:针对小型生物标志物的标准化免疫测定的可克隆的模拟分析探针。

获取原文
获取原文并翻译 | 示例
       

摘要

Most immunoassays use probes that convert concentrations of analytes into signal intensity. To prepare the probes, analytes are usually linked to a reporter protein (e.g., enzymes) with the aid of chemical reagents. However, these conventional methods yield a mixture of heterogeneous products and consequently reduce assay performance. "Clonable" homogeneous probes, i.e., recombinant molecules in which a target protein is genetically fused to a reporter with a defined coupling ratio, are now available for analyzing protein biomarker concentrations. Here, we have expanded this strategy to measure small biomarkers (haptens) by genetically fusing proteinaceous molecules that mimic target haptens with enzymes. 11-Deoxycortisol (11-DC) was chosen as the model hapten, and the β-type anti-idiotype antibodies (βId-Abs) that recognize the paratope of anti-hapten antibodies were used as the target hapten mimic. The V_H and V_L genes of a βId-Ab, targeting a mouse anti-11-DC antibody (CET-M8), were assembled to encode a single-chain Fv fragment (βId-scFv), which was then fused with a gene encoding a variant of alkaline phosphatase. The product, βId-scFv-ALP' protein, had satisfactory enzyme activity and bound to CET-M8 in a competitive manner with 11-DC. A colorimetric enzyme-linked immunosorbent assay (ELISA) for 11-DC, based on the competitive reaction between the analyte and βId-scFv-ALP' against immobilized CET-M8, was found to be sensitive (limit of detection = 22 pg/assay) and specific (cross-reactivity with cortisol, 0.24%) for clinical use and could be used to determine serum 11-DC levels after a simple solvent extraction. The anti-idiotype scFv-enzyme fusion proteins proposed here can be prepared reproducibly as homogeneous products with a 1:1 coupling ratio and would facilitate standardization of immunoassays for small biomarkers.
机译:大多数免疫分析都使用将分析物浓度转换为信号强度的探针。为了制备探针,通常在化学试剂的帮助下将分析物与报道蛋白(例如酶)连接。然而,这些常规方法产生了异质产物的混合物,因此降低了测定性能。现在可以使用“可克隆的”均质探针,即重组分子,其中靶蛋白以限定的偶联率遗传融合到报道分子上,用于分析蛋白质生物标记物的浓度。在这里,我们将这种策略扩展到了通过遗传融合模拟目标半抗原的蛋白质分子与酶来测量小型生物标志物(半抗原)的能力。选择11-脱氧皮质醇(11-DC)作为模型半抗原,将识别抗半抗原抗体对位的β型抗独特型抗体(βId-Abs)用作目标半抗原模拟物。组装靶向小鼠抗-11-DC抗体(CET-M8)的βId-Ab的V_H和V_L基因,以编码单链Fv片段(βId-scFv),然后将其与编码碱性磷酸酶的一种变体。产物βId-scFv-ALP'蛋白具有令人满意的酶活性,并与11-DC竞争地与CET-M8结合。基于分析物和βId-scFv-ALP'对固定化CET-M8的竞争反应,对11-DC进行比色酶联免疫吸附测定(ELISA)被认为是敏感的(检测限= 22 pg /测定)和特异性(与皮质醇的交叉反应性,为0.24%)用于临床,可在简单的溶剂提取后用于确定血清11-DC水平。此处提出的抗独特型scFv-酶融合蛋白可以可复制的形式制备为均一的产品,具有1:1的偶联率,并且有助于小生物标记物的免疫测定标准化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号